Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain
Jennifer R. Deuis(The University of Queensland), Irina Vetter(Centre National de la Recherche Scientifique), Christian Weidner(Friedrich-Alexander-Universität Erlangen-Nürnberg), Richard J. Lewis(AstraZeneca (Netherlands)), Silmara Rodrigues de Sousa(The University of Queensland), Tal Hoffmann, Zoltan Dekan(The University of Queensland), Paul F. Alewood(The University of Queensland), Katharina Zimmermann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Thomas Durek(The University of Queensland), Zoltán Winter(Friedrich-Alexander-Universität Erlangen-Nürnberg), Mohammed A. Nassar(University of Sheffield), Joshua S. Wingerd(The University of Queensland)
Cited by 116
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
|Cancer Cell|2013|680
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654